Insight Wealth Strategies, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Insight Wealth Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $202,831 - $239,613	-429 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $2,680 - $3,289	-6 Reduced 1.38%	429 $203,000
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $36,829 - $46,814	77 Added 21.51%	435 $210,000
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $18,521 - $22,379	34 Added 10.49%	358 $200,000
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $159,835 - $208,630	324 New	324 $202,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Wealth Strategies, LLC with notifications on news.